Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stigma and ART initiation among people with HIV and a lifetime history of illicit drug use in Saint-Petersburg, Russia-A prospective cohort analysis.
Vetrova M, Lodi S, Rateau L, Patts G, Blokhina E, Palatkin V, Yaroslavtseva T, Toussova O, Bushara N, Bendiks S, Gnatienko N, Krupitsky E, Lioznov D, Samet JH, Lunze K. Vetrova M, et al. Among authors: palatkin v. Int J Drug Policy. 2022 Apr;102:103600. doi: 10.1016/j.drugpo.2022.103600. Epub 2022 Feb 5. Int J Drug Policy. 2022. PMID: 35134598 Free PMC article.
Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial.
Krupitsky E, Blokhina E, Zvartau E, Verbitskaya E, Lioznov D, Yaroslavtseva T, Palatkin V, Vetrova M, Bushara N, Burakov A, Masalov D, Mamontova O, Langleben D, Poole S, Gross R, Woody G. Krupitsky E, et al. Among authors: palatkin v. Lancet HIV. 2019 Apr;6(4):e221-e229. doi: 10.1016/S2352-3018(18)30362-X. Epub 2019 Mar 14. Lancet HIV. 2019. PMID: 30880163 Free PMC article. Clinical Trial.
Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence.
Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Wahlgren V, Tsoy-Podosenin M, Bushara N, Burakov A, Masalov D, Romanova T, Tyurina A, Palatkin V, Slavina T, Pecoraro A, Woody GE. Krupitsky E, et al. Among authors: palatkin v. Arch Gen Psychiatry. 2012 Sep;69(9):973-81. doi: 10.1001/archgenpsychiatry.2012.1a. Arch Gen Psychiatry. 2012. PMID: 22945623 Free PMC article. Clinical Trial.
Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia.
Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Tsoy M, Wahlgren V, Burakov A, Masalov D, Romanova TN, Palatkin V, Tyurina A, Yaroslavtseva T, Sinha R, Kosten TR. Krupitsky E, et al. Among authors: palatkin v. Drug Alcohol Depend. 2013 Oct 1;132(3):674-80. doi: 10.1016/j.drugalcdep.2013.04.021. Epub 2013 May 15. Drug Alcohol Depend. 2013. PMID: 23683793 Free PMC article. Clinical Trial.
Anhedonia, depression, anxiety, and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant.
Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Wahlgren V, Tsoy-Podosenin M, Bushara N, Burakov A, Masalov D, Romanova T, Tyurina A, Palatkin V, Yaroslavtseva T, Pecoraro A, Woody G. Krupitsky E, et al. Among authors: palatkin v. Am J Drug Alcohol Abuse. 2016 Sep;42(5):614-620. doi: 10.1080/00952990.2016.1197231. Epub 2016 Jul 19. Am J Drug Alcohol Abuse. 2016. PMID: 27436632 Free PMC article. Clinical Trial.
[A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО, Krupitsky ЕМ, Blokhina ЕА, Verbitskaya ЕV, Brodyansky VМ, Alekseeva NP, Bushara NМ, Yaroslavtseva ТS, Palatkin VY, Masalov DV, Burakov АМ, Romanova ТN, Sulimov GY, Grinenko AY, Kosten Т, Nielsen D, Zvartau EE. Kibitov АО, et al. Among authors: palatkin vy. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(11. Vyp. 2):36-48. doi: 10.17116/jnevro201611611236-48. Zh Nevrol Psikhiatr Im S S Korsakova. 2016. PMID: 28300812 Clinical Trial. Russian.
[Anhedonia, depression, anxiety, and craving in opioid dependent patients stabilized on oral naltrexone or naltrexone implant].
Krupitsky EM, Zvartau EE, Blokhina EA, Verbitskaya EV, Wahlgren VY, Tsoy-Podosenin MV, Bushara NM, Burakov AM, Masalov DV, Romanova TN, Tiurina AA, Palatkin VY, Yaroslavtseva TS, Sulimov GY, Pecoraro A, Woody G. Krupitsky EM, et al. Among authors: palatkin vy. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(1. Vyp. 2):26-33. doi: 10.17116/jnevro20181181226-33. Zh Nevrol Psikhiatr Im S S Korsakova. 2018. PMID: 29658501 Clinical Trial. Russian.
[Stabilization of remission in patients with opioid dependence with naltrexone implant: a pharmacogenetic approach].
Krupitsky ЕМ, Kibitov АО, Blokhina ЕА, Verbitskaya ЕV, Brodyansky VМ, Alekseeva NP, Bushara NМ, Yaroslavtseva ТS, Palatkin VY, Masalov DV, Burakov АМ, Romanova ТN, Sulimov GY, Kosten Т, Nielsen D, Zvartau EE, Woody D. Krupitsky ЕМ, et al. Among authors: palatkin vy. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(4 Pt 2):14-23. doi: 10.17116/jnevro20151154214-23. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26288297 Russian.
[A double-blind randomized placebo-controlled study of the efficacy of the combined treatment with naltrexone and guanfacine for relapse prevention in opiate dependence].
Krupitsky EM, Blokhina EA, Zvartau EE, Verbitskaya VE, Bushara EM, Tiurina AA, Palatkin VY, Yaroslavtseva TS, Burakov AM, Masalov DV, Romanova TN, Grininko AY, Sinha R, Kosten T. Krupitsky EM, et al. Among authors: palatkin vy. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):39-46. doi: 10.17116/jnevro201511510139-46. Zh Nevrol Psikhiatr Im S S Korsakova. 2015. PMID: 26525620 Clinical Trial. Russian.